Prevalence and characteristics in long COVID among adults with asthma in the United States

References

• Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, Sehrawat TS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601–615. doi:10.1038/s41591-021-01283-z.
   PubMed Web of Science ®Google Scholar
• Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102–e107. doi:10.1016/S1473-3099(21)00703-9.
   PubMed Web of Science ®Google Scholar
• Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, Clark A, Ntatsaki E, Vassiliou VS. Risk factors associated with post-COVID-19 Condition: a systematic review and meta-analysis. JAMA Intern Med. 2023;183(6):566–580. doi:10.1001/jamainternmed.2023.0750.
   PubMed Web of Science ®Google Scholar
• Office for National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/30march2023 (accessed 30 Mar 2023).
   Google Scholar
• Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, Ballouz T, Blyuss O, Bobkova P, Bonsel G, Borzakova S, et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328(16):1604–1615. doi:10.1001/jama.2022.18931.
   PubMed Web of Science ®Google Scholar
• O’Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, Karamchandani U, Simms-Williams N, Cassambai S, Ardavani A, et al. The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine. 2022;55:101762. doi:10.1016/j.eclinm.2022.101762.
   PubMedGoogle Scholar
• Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021;53(10):737–754. doi:10.1080/23744235.2021.1924397.
   PubMed Web of Science ®Google Scholar
• Philip KEJ, Buttery S, Williams P, Vijayakumar B, Tonkin J, Cumella A, Renwick L, Ogden L, Quint JK, Johnston SL, et al. Impact of COVID-19 on people with asthma: a mixed methods analysis from a UK wide survey. BMJ Open Respir Res. 2022;9(1):e001056. doi:10.1136/bmjresp-2021-001056.
   PubMed Web of Science ®Google Scholar
• Reilev M, Kristensen KB, Pottegård A, Lund LC, Hallas J, Ernst MT, Christiansen CF, Sørensen HT, Johansen NB, Brun NC, et al. Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort. Int J Epidemiol. 2020;49(5):1468–1481. doi:10.1093/ije/dyaa140.
   PubMed Web of Science ®Google Scholar
• Wang Z, Li Y, Gao Y, Fu Y, Lin J, Lei X, Zheng J, Jiang M. Global, regional, and national burden of asthma and its attributable risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Respir Res. 2023;24(1):169. doi:10.1186/s12931-023-02475-6.
   PubMed Web of Science ®Google Scholar
• Busse WW, Lemanske RF, Jr., Gern JE. Role of viral respiratory infections in asthma and asthma exacerbations. Lancet. 2010;376(9743):826–834. doi:10.1016/S0140-6736(10)61380-3.
   PubMed Web of Science ®Google Scholar
• Thompson EJ, Williams DM, Walker AJ, Mitchell RE, Niedzwiedz CL, Yang TC, Huggins CF, Kwong ASF, Silverwood RJ, Di Gessa G, et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13(1):3528. doi:10.1038/s41467-022-30836-0.
   PubMed Web of Science ®Google Scholar
• Laorden D, Domínguez-Ortega J, Carpio C, Barranco P, Villamañán E, Romero D, Quirce S, Álvarez-Sala R, ASMA@COVIDHULP group. Long COVID outcomes in an asthmatic cohort and its implications for asthma control. Respir Med. 2023;207:107092. doi:10.1016/j.rmed.2022.107092.
   PubMed Web of Science ®Google Scholar
• Sunata K, Miyata J, Terai H, Matsuyama E, Watase M, Namkoong H, Asakura T, Masaki K, Chubachi S, Ohgino K, et al. Asthma is a risk factor for general fatigue of long COVID in Japanese nation-wide cohort study. Allergol Int. 2023:S1323-8930(23)00115-6. doi:10.1016/j.alit.2023.11.003.
   PubMed Web of Science ®Google Scholar
• Palmon PA, Jackson DJ, Denlinger LC. COVID-19 infections and asthma. J Allergy Clin Immunol Pract. 2022;10(3):658–663. doi:10.1016/j.jaip.2021.10.072.
   PubMed Web of Science ®Google Scholar
• Gao YD, Agache I, Akdis M, Nadeau K, Klimek L, Jutel M, Akdis CA. The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19. Int Immunol. 2022;34(4):177–188. doi:10.1093/intimm/dxab107.
   PubMed Web of Science ®Google Scholar
• Abdelrahman MM, Abd-Elrahman NM, Bakheet TM. Persistence of symptoms after improvement of acute COVID19 infection, a longitudinal study. J Med Virol. 2021;93(10):5942–5946. doi:10.1002/jmv.27156.
   PubMed Web of Science ®Google Scholar
• Emecen AN, Keskin S, Turunc O, Suner AF, Siyve N, Basoglu Sensoy E, Dinc F, Kilinc O, Avkan Oguz V, Bayrak S, et al. The presence of symptoms within 6 months after COVID-19: a single-center longitudinal study. Ir J Med Sci. 2023;192(2):741–750. doi:10.1007/s11845-022-03072-0.
   PubMed Web of Science ®Google Scholar
• Ioannou GN, Baraff A, Fox A, Shahoumian T, Hickok A, O’Hare AM, Bohnert ASB, Boyko EJ, Maciejewski ML, Bowling CB, et al. Rates and factors associated with documentation of diagnostic codes for long COVID in the national veterans affairs health care system. JAMA Netw Open. 2022;5(7):e2224359. doi:10.1001/jamanetworkopen.2022.24359.
   PubMed Web of Science ®Google Scholar
• Jones R, Davis A, Stanley B, Julious S, Ryan D, Jackson DJ, Halpin DMG, Hickman K, Pinnock H, Quint JK, et al. Risk predictors and symptom features of long COVID within a broad primary care patient population including both tested and untested patients. Pragmat Obs Res. 2021;12:93–104. doi:10.2147/POR.S316186.
   PubMed Web of Science ®Google Scholar
• Kostev K, Smith L, Koyanagi A, Jacob L. Prevalence of and factors associated with post-coronavirus disease 2019 (COVID-19) condition in the 12 months after the diagnosis of COVID-19 in adults followed in general practices in Germany. Open Forum Infect Dis. 2022;9(7):ofac333. doi:10.1093/ofid/ofac333.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, Taverner T, Chandan JS, Brown K, Simms-Williams N, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28(8):1706–1714. doi:10.1038/s41591-022-01909-w.
   PubMed Web of Science ®Google Scholar
• National Center for Health Statistics. National Health Interview Survey, 2022 survey description. Hyattsville: Centers for Disease Control and Prevention. Available from: https://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHIS/2022/srvydesc-508.pdf (accessed Jun 2023).
   Google Scholar
• Pate CA, Zahran HS, Qin X, Johnson C, Hummelman E, Malilay J. Asthma surveillance – United States, 2006-2018. MMWR Surveill Summ. 2021;70(5):1–32. doi:10.15585/mmwr.ss7005a1.
   PubMed Web of Science ®Google Scholar
• National Center for Health Statistics. U.S. Census Bureau, Household Pulse Survey, 2022-2023. Long COVID. Centers for Disease Control and Prevention. Available from: https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm (accessed 8 Nov 2023).
   Google Scholar
• Muntean IA, Leru PM, Pintea I, Bocsan IC, Dobrican CT, Deleanu D. A retrospective study regarding the influence of COVID-19 disease on asthma. BMC Pulm Med. 2023;23(1):22. doi:10.1186/s12890-023-02309-7.
   PubMed Web of Science ®Google Scholar
• Robinson LB, Wang L, Fu X, Wallace ZS, Long AA, Zhang Y, Camargo CA, Jr, Blumenthal KG. COVID-19 severity in asthma patients: a multi-center matched cohort study. J Asthma. 2022;59(3):442–450. doi:10.1080/02770903.2020.1857396.
   PubMed Web of Science ®Google Scholar
• Pan D, Pareek M. Toward a universal definition of post-COVID-19 condition-how do we proceed? JAMA Netw Open. 2023;6(4):e235779. doi:10.1001/jamanetworkopen.2023.5779.
   PubMed Web of Science ®Google Scholar
• Chaichana U, Man KKC, Chen A, Wong ICK, George J, Wilson P, Wei L. Definition of post-COVID-19 condition among published research studies. JAMA Netw Open. 2023;6(4):e235856. doi:10.1001/jamanetworkopen.2023.5856.
   PubMed Web of Science ®Google Scholar
• Eggert LE, He Z, Collins W, Lee AS, Dhondalay G, Jiang SY, Fitzpatrick J, Snow TT, Pinsky BA, Artandi M, et al. Asthma phenotypes, associated comorbidities, and long-term symptoms in COVID-19. Allergy. 2022;77(1):173–185. doi:10.1111/all.14972.
   PubMed Web of Science ®Google Scholar
• Yang JM, Koh HY, Moon SY, Yoo IK, Ha EK, You S, Kim SY, Yon DK, Lee SW. Allergic disorders and susceptibility to and severity of COVID-19: a nationwide cohort study. J Allergy Clin Immunol. 2020;146(4):790–798. doi:10.1016/j.jaci.2020.08.008.
   PubMed Web of Science ®Google Scholar
• Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mulè G, Augello M, Mondatore D, Allegrini M, Cona A, et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2022;28(4):611.e9-611–e16. doi:10.1016/j.cmi.2021.11.002.
   Web of Science ®Google Scholar
• Khademi M, Vaziri-Harami R, Shams J. Prevalence of mental health problems and its associated factors among recovered COVID-19 patients during the pandemic: a single-center study. Front Psychiatry. 2021;12:602244. doi:10.3389/fpsyt.2021.602244.
   PubMed Web of Science ®Google Scholar
• Mohamed MS, Moulin TC, Schiöth HB. Sex differences in COVID-19: the role of androgens in disease severity and progression. Endocrine. 2021;71(1):3–8. doi:10.1007/s12020-020-02536-6.
   PubMed Web of Science ®Google Scholar
• Zeng F, Dai C, Cai P, Wang J, Xu L, Li J, Hu G, Wang Z, Zheng F, Wang L. A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between sex. J Med Virol. 2020;92(10):2050–2054. doi:10.1002/jmv.25989.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2023. Available from: http://www.ginasthma.org (accessed Jul 2023).
   Google Scholar
• Florencio LL, Fernández-de-Las-Peñas C. Long COVID: systemic inflammation and obesity as therapeutic targets. Lancet Respir Med. 2022;10(8):726–727. doi:10.1016/S2213-2600(22)00159-X.
   PubMed Web of Science ®Google Scholar
• Sykes DL, Faruqi S, Holdsworth L, Crooks MG. Impact of COVID-19 on COPD and asthma admissions, and the pandemic from a patient’s perspective. ERJ Open Res. 2021;7(1):00822–2020. doi:10.1183/23120541.00822-2020.
   PubMedGoogle Scholar
• Mansfield KE, Mathur R, Tazare J, Henderson AD, Mulick AR, Carreira H, Matthews AA, Bidulka P, Gayle A, Forbes H, et al. Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study. Lancet Digit Health. 2021;3(4):e217–e230. doi:10.1016/S2589-7500(21)00017-0.
   PubMedGoogle Scholar
• Philip K, Cumella A, Farrington-Douglas J, Laffan M, Hopkinson N. Respiratory patient experience of measures to reduce risk of COVID-19: findings from a descriptive cross-sectional UK wide survey. BMJ Open. 2020;10(9):e040951. doi:10.1136/bmjopen-2020-040951.
   PubMed Web of Science ®Google Scholar
• Romão M, Bulhosa C, Mendes Z, Sousa C, Silva G, Pereira M, Bernardo F, Teixeira Rodrigues A, Fonseca JA, Correia de Sousa J. Characteristics of oral corticosteroid users among persons with asthma on GINA step 3 therapy and above: a cross-sectional study in portuguese community pharmacies. J Asthma Allergy. 2022;15:1579–1592. doi:10.2147/JAA.S377896.
   PubMed Web of Science ®Google Scholar
• Cataldo D, Louis R, Michils A, Peché R, Pilette C, Schleich F, Ninane V, Hanon S. Severe asthma: oral corticosteroid alternatives and the need for optimal referral pathways. J Asthma. 2021;58(4):448–458. doi:10.1080/02770903.2019.1705335.
   PubMed Web of Science ®Google Scholar
• Hasan SS, Capstick T, Zaidi STR, Kow CS, Merchant HA. Use of corticosteroids in asthma and COPD patients with or without COVID-19. Respir Med. 2020;170:106045. doi:10.1016/j.rmed.2020.106045.
   PubMed Web of Science ®Google Scholar
• Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re’em Y, Redfield S, Austin JP, Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi:10.1016/j.eclinm.2021.101019.
   PubMedGoogle Scholar
• Vélez-Santamaría R, Fernández-Solana J, Méndez-López F, Domínguez-García M, González-Bernal JJ, Magallón-Botaya R, Oliván-Blázquez B, González-Santos J, Santamaría-Peláez M. Functionality, physical activity, fatigue and quality of life in patients with acute COVID-19 and Long COVID infection. Sci Rep. 2023;13(1):19907. doi:10.1038/s41598-023-47218-1.
   PubMedGoogle Scholar